Early research (Phase 1)Study completedNCT01497184What this trial is testingInfusion of Allogeneic CD19-Specific T Cells From Peripheral BloodWho this might be right forLeukemiaLymphoma M.D. Anderson Cancer Center 95
Testing effectiveness (Phase 2)Ended earlyNCT00387426What this trial is testingSunitinib in Treating Patients With Idiopathic MyelofibrosisWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+29 more National Cancer Institute (NCI) 14
Early research (Phase 1)UnknownNCT04007978What this trial is testingAnti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell MalignanciesWho this might be right forB Cell LymphomaAcute Lymphoblastic Leukemia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Not applicableUnknownNCT00757614What this trial is testingStudy of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomWho this might be right forBladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more Cancer Research UK 14,000
Early research (Phase 1)Ended earlyNCT00354185What this trial is testingPXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more National Cancer Institute (NCI) 36
Very early researchActive Not RecruitingNCT06765876What this trial is testingCART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I TrialWho this might be right forLeukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more Institute of Hematology and Blood Transfusion, Czech Republic 18
Testing effectiveness (Phase 2)Study completedNCT00002504What this trial is testingInterleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)Looking for participantsNCT06381817What this trial is testingHaplo-cord HCT vs. Haplo-HCT for T-ALL PatientsWho this might be right forAcute T Cell Lymphoblastic LeukemiaHaploidentical Hematopoietic Stem Cell TransplantationCord Blood The First Affiliated Hospital of Soochow University 146
Early research (Phase 1)UnknownNCT04594135What this trial is testingAnti-CD5 CAR T Cells for Relapsed/Refractory T Cell MalignanciesWho this might be right forT-cell Acute Lymphoblastic LeukemiaT-cell Non-Hodgkin Lymphoma iCell Gene Therapeutics 20
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableStudy completedNCT00096135What this trial is testingCombination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesWho this might be right forLeukemia Children's Oncology Group 168
Testing effectiveness (Phase 2)Study completedNCT02631746What this trial is testingNivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/LymphomaWho this might be right forAcute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more National Cancer Institute (NCI) 3
Early research (Phase 1)Study completedNCT00769288What this trial is testingFAU in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT01295710What this trial is testingStudy of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)Who this might be right forGVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more Neovii Biotech 260
Early research (Phase 1)Ended earlyNCT00618696What this trial is testingYttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 4
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Looking for participantsNCT07188610What this trial is testingPA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/LymphomaWho this might be right forCD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma PersonGen BioTherapeutics (Suzhou) Co., Ltd. 100
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35